HES1 and neuroendocrine neoplasm: In neuroendocrine tumors (NETs), these same signaling pathways, as well as hairy enhancer of split 1 (Hes-1)/achaete–scute complex-like 1 (ASCL-1), have been shown to impact tumorigenesis via Notch signaling (7–14).